文献速递性腺与生殖内分泌

原发性卵巢功能不全中非编码RNA的最新见解:聚焦机制与治疗

Recent Insights into Noncoding RNAs in Primary Ovarian Insufficiency: Focus on Mechanisms and Treatments.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

本综述概述了与原发性卵巢功能不全(POI)相关的各类非编码RNA(包括miRNA、lncRNA、circRNA和siRNA)的生物合成,并总结了其在疾病发生和进展调控中作用的证据;尽管各研究结果存在差异,现有文献总体支持失调的非编码RNA在POI中发挥重要作用;源自间充质干细胞分泌外泌体的非编码RNA在多种疾病中起关键作用并具有相当的治疗潜力,但非编码RNA治疗POI的潜力需进一步研究。

要点

  • 失调的miRNA、lncRNA、circRNA和siRNA在POI中发挥重要作用。
  • 间充质干细胞分泌外泌体来源的非编码RNA具有相当的治疗潜力。
  • 非编码RNA治疗POI的潜力需进一步研究。

核心结论

  • 现有文献总体支持失调的非编码RNA在POI中发挥重要作用的结论,但各研究结果存在差异。
  • 非编码RNA治疗POI的潜力需进一步研究。
  • 源自间充质干细胞分泌外泌体的非编码RNA在多种疾病中起关键作用并具有相当的治疗潜力。

研究设计与样本

  • 本综述通过PubMed和Google Scholar检索2003年至2022年间发表的文章,检索词包括非编码RNA、原发性卵巢功能不全、卵巢早衰、miRNA、lncRNA、siRNA、circRNA、病理生理学和潜在治疗等。
  • 所有文章由作者独立筛选以确定合格性。

主要发现

  • 本综述总结了miRNA、lncRNA、siRNA和circRNA在POI中的生物学功能与合成,并讨论了临床、体外和体内研究的发现。
  • 尽管各研究结果存在差异,现有文献总体支持失调的非编码RNA在POI中发挥重要作用。
  • 源自间充质干细胞分泌外泌体的非编码RNA在多种疾病中起关键作用并具有相当的治疗潜力。

局限性

  • 各研究结果存在差异。
  • 非编码RNA治疗POI的潜力需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Primary ovarian insufficiency (POI) is a heterogeneous disease with an unknown underlying trigger or root cause. Recently many studies evaluated noncoding RNAs (ncRNAs), especially microRNAs (miRNAs), long noncoding RNA (lncRNAs), circular RNAs (circRNAs), and small interfering RNAs (siRNAs) for their associations with POI. EVIDENCE ACQUISITION: In this review, we outline the biogenesis of various ncRNAs relevant to POI and summarize the evidence for their roles in the regulation of disease occurrence and progression. Articles from 2003 to 2022 were selected for relevance, validity, and quality from results obtained in PubMed and Google Scholar using the following search terms: noncoding RNAs; primary ovarian insufficiency; premature ovarian failure; noncoding RNAs and primary ovarian insufficiency/premature ovarian failure; miRNAs and primary ovarian insufficiency/premature ovarian failure; lncRNAs and primary ovarian insufficiency/premature ovarian failure; siRNAs and primary ovarian insufficiency/premature ovarian failure; circRNAs and primary ovarian insufficiency/premature ovarian failure; pathophysiology; and potential treatment. All articles were independently screened for eligibility by the authors. EVIDENCE SYNTHESIS: This review summarizes the biological functions and synthesis of miRNAs, lncRNAs, siRNAs, and circRNAs in POI and discusses the findings of clinical and in vitro and in vivo studies. Although there is variability in the findings of individual studies, overall the available literature justifies the conclusion that dysregulated ncRNAs play significant roles in POI. CONCLUSION: The potential of ncRNAs in the treatment of POI requires further investigation, as ncRNAs derived from mesenchymal stem cell-secreted exosomes play pivotal roles and have considerable therapeutic potential in a multitude of diseases.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Zhang JH, Chen JH, Guo B, et al. Recent Insights into Noncoding RNAs in Primary Ovarian Insufficiency: Focus on Mechanisms and Treatments. J Clin Endocrinol Metab. 2023. PMID: 36735959. doi:10.1210/clinem/dgad070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。